Keyphrases
Clinical Trials
100%
High-throughput
100%
Molecular Profiling
100%
Human Glioma
100%
Glioma
75%
Genetic Modification
50%
Patient Selection
50%
Gene Amplification
50%
Glioma Patients
50%
Cancer Genes
25%
Clinical Evaluation
25%
PIK3CA
25%
Cancer Types
25%
Signaling Pathway
25%
Targeted Therapy
25%
Solid Cancer
25%
Glioblastoma
25%
Isocitrate Dehydrogenase 1 (IDH1)
25%
Molecular Diagnostics
25%
Histological Subtypes
25%
Clinical Phenotype
25%
Enrollment Criteria
25%
AKT1
25%
Clinical Assay
25%
Malignant Glioma
25%
Platelet-derived Growth Factor Receptor (PDGFR)
25%
Molecular Differences
25%
Driver mutations
25%
Molecular Subtypes
25%
MGMT Promoter Methylation
25%
Tumor Genotyping
25%
1p/19q Codeletion
25%
SNaPshot Genotyping
25%
Rational Selection
25%
Clinical Responsiveness
25%
Medicine and Dentistry
Ganglioglioma
100%
Molecular Profiling
100%
Clinical Trial
83%
Gene Mutation
33%
Epidermal Growth Factor Receptor
33%
Glioblastoma
33%
Genotype
33%
Gene Amplification
33%
Malignant Neoplasm
16%
Neoplasm
16%
Cancer Types
16%
Targeted Therapy
16%
Promoter Region
16%
Signal Transduction
16%
Tumor Gene
16%
Patient Selection
16%
Methylation
16%
Molecular Diagnosis
16%
Neuroscience
Epidermal Growth Factor Receptor
100%
Gene Mutation
100%
Gene Amplification
100%
Promoter Region
50%
Cell Signaling
50%
Oncogene
50%
AKT1
50%
Methylation
50%
Tumor Gene
50%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Epidermal Growth Factor Receptor
40%
Gene Mutation
40%
Genotyping
40%
Gene Amplification
40%
Signal Transduction
20%
Promoter Region
20%
Oncogene
20%
Tumor Gene
20%
KRAS
20%
Methylation
20%
AKT1
20%
IDH1
20%
Platelet Derived Growth Factor Receptor Alpha
20%